Search research articles
Contact Us
Filters
Showing results (11-20 of 101) with videos related to
Page
of 11
Sort By:
Trends in Cancer
|
October 2, 2023
Enhancing dendritic cells by inhibiting BCL2
Christopher A G Booth, Andrew A Lane
Blood
|
March 19, 2025
PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target
Qingyu Luo, Amanda L Fortune, Andrew A Lane
Blood
|
October 7, 2024
How I treat blastic plasmacytoid dendritic cell neoplasm
Mohamed A Kharfan-Dabaja, Andrew A Lane, Naveen Pemmaraju
Expert Review of Clinical Pharmacology
|
August 30, 2019
Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm
Minas P Economides, Deborah McCue, Andrew A Lane, et al.
American Journal of Hematology
|
January 23, 2010
von Willebrand disease type 2N: uncovering a congenital bleeding disorder in a patient with hepatitis C, cirrhosis, and coagulopathy
Andrew A Lane, Elizabeth M Van Cott, Bimalangshu R Dey
Current Hematologic Malignancy Reports
|
August 6, 2016
Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Naveen Pemmaraju, Vikas Gupta, Michael A Thompson, et al.
American Journal of Clinical Pathology
|
March 7, 2023
Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells
Sarah J Wu, Sam Sadigh, Andrew A Lane, et al.
Haematologica
|
August 5, 2005
Murine acute promyelocytic leukemia cells can be recognized and cleared in vivo by adaptive immune mechanisms
Jessica L Pollock, Andrew A Lane, Kelly Schrimpf, et al.
Cell
|
June 29, 2023
Loss of chromosome Y in primary tumors
Meifang Qi, Jiali Pang, Irene Mitsiades, et al.
Current Hematologic Malignancy Reports
|
October 20, 2018
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN-Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 101) with videos related to
Sort By:
Page
of 11
Trends in Cancer
|
October 2, 2023
Enhancing dendritic cells by inhibiting BCL2
Christopher A G Booth, Andrew A Lane
Blood
|
March 19, 2025
PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target
Qingyu Luo, Amanda L Fortune, Andrew A Lane
Blood
|
October 7, 2024
How I treat blastic plasmacytoid dendritic cell neoplasm
Mohamed A Kharfan-Dabaja, Andrew A Lane, Naveen Pemmaraju
Expert Review of Clinical Pharmacology
|
August 30, 2019
Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm
Minas P Economides, Deborah McCue, Andrew A Lane, et al.
American Journal of Hematology
|
January 23, 2010
von Willebrand disease type 2N: uncovering a congenital bleeding disorder in a patient with hepatitis C, cirrhosis, and coagulopathy
Andrew A Lane, Elizabeth M Van Cott, Bimalangshu R Dey
Current Hematologic Malignancy Reports
|
August 6, 2016
Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Naveen Pemmaraju, Vikas Gupta, Michael A Thompson, et al.
American Journal of Clinical Pathology
|
March 7, 2023
Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells
Sarah J Wu, Sam Sadigh, Andrew A Lane, et al.
Haematologica
|
August 5, 2005
Murine acute promyelocytic leukemia cells can be recognized and cleared in vivo by adaptive immune mechanisms
Jessica L Pollock, Andrew A Lane, Kelly Schrimpf, et al.
Cell
|
June 29, 2023
Loss of chromosome Y in primary tumors
Meifang Qi, Jiali Pang, Irene Mitsiades, et al.
Current Hematologic Malignancy Reports
|
October 20, 2018
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN-Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al.
Page
of 11